Precisio Biotix Therapeutics, Inc. Announces Dosing of a 1st Patient with ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection
The FDA approved this treatment under a compassionate.
July 3, 2025
The FDA approved this treatment under a compassionate.